A Stable Clinical Trial Study Team with Trial Legacy Capability Makes All the Difference
The smaller, niche CRO that is well managed, with stable clinical trial study teams that provide trial legacy capability, and…
Why it Matters to Mid-Size Study Sponsors that Your CRO Acts Like a SMO – Case in Point
Valuable activities SMOs and CROs can provide sponsors are identification, activation, and engagement. Ideally, study sponsors can gain: rapid patient…
Basket Trials: How Qualified Oncology CRAs Address & Overcome the Challenges
Basket trials, along with umbrella trials and platform trials, are classified as master protocols which investigate multiple hypothesis throughout concurrent…
Diversity in Clinical Trials – How to Attain It?
All agree that ethnic groups are massively under-represented when it comes to clinical trials, and although barriers to diversity in…
25 Years of Unparalleled Canadian Oncology Clinical Research Experience
Scimega Research, Canada’s premier oncology contract research organization (CRO), was founded twenty-five years ago by two dynamic entrepreneurs, Denise Deakin…
Get a Multi Niche Web™ of Specialized Expertise to Work for Your Oncology Clinical Trial
For the mid-size and smaller biopharma company the stakes are always high for every trial conducted. With limited resources and…
eTMF Best Practice for a Lean Team
The TMF is the official record of the clinical study for Regulatory Authorities, be it the FDA, Health Canada, or…
Recovering a Derailed Clinical Trial – Best Practices
Partnerships sometimes do not work out as intended. For medium size and smaller biotech companies enlisting the services of a…
Canada: For Your Phase 3 Global Trial Expansion
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
Doubly Nimble: why you should open global P1 clinical trials in Canada on Day 1
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…